The Clorox Company (CLX) reported a 25.5% decline in share price year-to-date, while the industry has grown by 2.2%. As of Q3 2025, Clorox focuses on consumer-centric innovation with successful premium products like Scentiva disinfecting sprays and upgraded items designed to meet evolving consumer needs. The company maintains a forward price-to-earnings ratio of 18.0, below the industry average of 20.23.
Clorox aims for a dual strategy of premiumization and budget options, catering to both high-end and budget-conscious consumers. The Zacks Consensus Estimate projects a 14.9% growth in earnings for 2025, followed by a decline of 5.4% in 2026. Clorox plans to continue investing in R&D and its supply chain to drive long-term growth despite market challenges.
Competitors in Clorox’s space include Procter & Gamble (PG), Colgate-Palmolive (CL), and Church & Dwight (CHD), all utilizing various innovation strategies to capture market share in the consumer staples sector.
